Skip to main content
PepStack

TB-500

Wound Healing & Regeneration
Thymosin Beta-4Tß4TB500

Overview

TB-500, also known as Thymosin Beta-4, Tß4, or TB500, is a synthetic version of a naturally occurring peptide present in almost all human and animal cells. It is composed of 43 amino acids and is synthesized through solid-phase peptide synthesis. TB-500 is structurally related to the thymosin beta-4 peptide, which is involved in various cellular processes, including cell migration and differentiation. Researchers have primarily investigated TB-500 for its potential role in wound healing and tissue regeneration. Studies have shown that it may promote angiogenesis, reduce inflammation, and accelerate the healing of injuries, particularly in muscle and tendon tissues. Additionally, TB-500 has been explored for its potential benefits in reducing fibrosis and improving hair growth. The mechanism of action of TB-500 involves the modulation of actin, a protein that plays a critical role in cell movement and structure. By binding to actin, TB-500 facilitates cell migration and proliferation, which are essential processes in wound healing and tissue repair. It also influences the expression of various growth factors, contributing to its regenerative effects. Pharmacokinetic studies of TB-500 suggest that it has a relatively short half-life, with subcutaneous administration showing a half-life of approximately 2-4 hours. The peptide is stable when lyophilized but should be used shortly after reconstitution. Bioavailability varies by route, with subcutaneous and intramuscular injections being the most common. Currently, TB-500 is not approved by major regulatory bodies such as the FDA for medical use. It is primarily available as a research chemical, and its use in humans is limited to experimental settings. Regulatory status varies by country, and it is important for researchers to be aware of local regulations regarding its use.

Mechanism of Action

TB-500 primarily acts by binding to actin, a key protein involved in cell movement and structure. This interaction promotes cell migration and proliferation, essential for wound healing and tissue repair. Additionally, TB-500 influences the expression of growth factors that further support regenerative processes.

Molecular Data

FormulaC38H68N10O14
Molecular Weight889 g/mol
CAS Number885340-08-9
PubChem CID62707662

Half-Life

Subcutaneous~2-4 hours
IntranasalNot applicable
OralPoor bioavailability

Bioavailability and half-life can vary based on administration route and individual metabolic factors.

Storage

Lyophilized

Stable for 2+ years at -20°C, 12 months at 4°C

Reconstituted

Use within 14 days when refrigerated at 4°C

Avoid

Avoid repeated freeze-thaw cycles, direct light

Solvent

Bacteriostatic water or sterile saline recommended

Solubility

TB-500 is soluble in water and saline solutions.

Legal Status

🇩🇪DE

Not approved as a medicinal product. Not a controlled substance. Sale as research chemical is a legal grey area.

🇺🇸US

Not approved by the FDA for medical use. Not a controlled substance.

🇦🇺AU

Not approved by the TGA for therapeutic use.

🇬🇧UK

Not approved by the MHRA for medical use.

Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.

7 Research Publications

Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.

Human

Stem cell reports · 2025

Researchers studied brain organoids to understand Alzheimer’s disease and found that a protein called thymosin beta 4 (Tβ4) is significantly reduced in neurons affected by the disease. They observed that treatment with Tβ4 improved neuron development and reduced harmful protein buildup in both brain organoids and mouse models. This suggests Tβ4 could be a promising target for future Alzheimer’s interventions.

  • Researchers found that neurons in Alzheimer’s disease organoids had fewer mature cells and increased harmful protein production compared to healthy controls.
  • The gene TMSB4X, which produces thymosin beta 4, was significantly lower in Alzheimer’s affected neurons.
  • Treatment with Tβ4 improved neuron development and reduced harmful protein levels in both brain organoids and mouse models of Alzheimer’s disease.
PubMed

The subcommissural organ regulates brain development via secreted peptides.

Unknown

Nature neuroscience · 2024

Researchers studied the subcommissural organ (SCO), a small gland in the brain, to understand its role in brain development. They found that when SCO cells were removed during embryonic development, it led to serious brain issues. Introducing specific peptides from the SCO helped to reverse some of these developmental problems.

  • Researchers found that the SCO is crucial for proper brain development.
  • Removing SCO cells in mice caused severe brain abnormalities, including hydrocephalus and neuronal migration issues.
  • Reintroducing specific peptides from the SCO significantly improved developmental defects in the affected brains.
PubMed

Cardioprotection by Thymosin Beta 4.

Review

Vitamins and hormones · 2016

Researchers observed that thymosin beta 4 (Tβ4) can reduce heart damage and improve heart function after ischemic injury in animal models. The study found that Tβ4 promotes blood vessel growth and has properties that prevent fibrosis, which may contribute to its protective effects on the heart. These findings suggest that Tβ4 interacts with various cellular pathways to support heart recovery.

  • Tβ4 reduces the size of heart damage and preserves heart function in preclinical models.
  • Tβ4 promotes the growth of blood vessels and helps convert inactive heart tissue into a functioning state after injury.
  • Tβ4 has antifibrotic effects, indicating its potential to prevent scarring in heart tissue.
PubMed

The beta-thymosin enigma.

Review

Annals of the New York Academy of Sciences · 2007

Researchers reviewed how thymosin beta-4 (Tbeta-4) influences the behavior of actin, a protein crucial for cell movement and structure. They found that Tbeta-4 can change the arrangement of actin in various cells, affecting their functions related to movement and signaling.

  • Researchers observed that Tbeta-4 modulates the availability of actin monomers, which are essential for cell movement.
  • The study found that altering Tbeta-4 levels can significantly change the structure of the actin cytoskeleton.
  • Researchers noted that the effects of beta-thymosins on cells are complex, involving both direct and indirect influences on actin dynamics and cellular signaling.
PubMed

beta-Thymosins.

Review

Annals of the New York Academy of Sciences · 2007

Researchers reviewed the role of beta-thymosins, particularly thymosin beta(4), in various biological functions, including immune response and wound healing. They found that these peptides can bind to actin, a protein involved in cell movement and structure, and are present in many cells throughout the body.

  • Thymosin beta(4) is a key peptide that sequesters G-actin, allowing for rapid binding and release.
  • Beta-thymosins are important in various biological processes, although their specific molecular mechanisms are not well understood.
  • Thymosin beta(4) is found in both the nucleus and cytoplasm of cells, suggesting a broader role in cellular functions.
PubMed

Thymosin beta 4 interactions.

Review

Vitamins and hormones · 2003

Researchers reviewed the protein thymosin beta 4, which plays various roles in the body, including influencing cell movement and immune responses. They found that its flexible structure allows it to interact with different molecules, potentially linking important cellular processes.

  • Thymosin beta 4 is a small protein with multiple functions, including acting as an anti-inflammatory agent.
  • The protein's largely unfolded structure may enable it to recognize various molecular targets.
  • This flexibility could connect the actin cytoskeleton to key immune and cell growth signaling pathways.
PubMed

The platelet cytoskeleton.

Review

Thrombosis and haemostasis · 1993

Researchers observed that platelets, which are crucial for blood clotting, have a complex structure called the cytoskeleton that changes when activated. This study highlights how actin filaments within platelets reorganize to support their function during clot formation.

  • The platelet cytoskeleton consists of two main components: cytoplasmic actin filaments and a membrane skeleton.
  • In resting platelets, only 30-40% of actin is in filament form, but this increases rapidly upon activation.
  • Activation leads to significant changes in the cytoskeleton, facilitating platelet aggregation and interaction with other signaling molecules.
PubMed

Track TB-500 in PepStack

Log your research cycles, set reminders and visualize serum levels.

This page is for informational and research purposes only. All information is based on published scientific literature. Nothing on this page constitutes medical advice or replaces consultation with a qualified healthcare professional.